Reply: Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations

Mov Disord Clin Pract. 2023 Jun 30;10(8):1235-1236. doi: 10.1002/mdc3.13818. eCollection 2023 Aug.

Cady K Block¹, Margi Patel², Benjamin B Risk^{3

4}, Ekaterina Staikova¹, David Loring¹, Christine D Esper¹, Laura Scorr¹, Lenora Higginbotham^{1

4}, Pratibha Aia¹, Mahlon R De Long¹, Thomas Wichmann^{1

4}, Stewart A Factor^{1

4}, Nicholas Au Yong⁵, Jon T Willie⁶, Nicholas M Boulis⁵, Robert E Gross⁵, Cathrin Buetefisch⁷, Svjetlana Miocinovic^{1

4}

¹ Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
² Department of Neurology Texas A&M University, Baylor University Medical Center Dallas Texas USA.
³ Department of Biostatistics and Bioinformatics Emory University Rollins School of Public Health Atlanta Georgia USA.
⁴ Emory Udall Center of Excellence in Parkinson's Disease Research Emory National Primate Research Center Atlanta Georgia USA.
⁵ Department of Neurosurgery Emory University School of Medicine Atlanta Georgia USA.
⁶ Department of Neurosurgery, Neurology, and Psychiatry Washington University School of Medicine St Louis Missouri USA.
⁷ Department of Neurology, Rehabilitation Medicine, and Radiology Emory University School of Medicine Atlanta Georgia USA.

No abstract available

Keywords: DBS; cognitive impairment; dementia; neurocognitive screening; outcomes.